Cryoglobulins

Journal of Clinical Pathology

Volumn 55, Issue 1, 2002, Pages 4-13

  Ferri, C ^a   Zignego, A L ^b   Pileri, S A ^c  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CRYOGLOBULIN; CYCLOPHOSPHAMIDE; HEPATITIS C VACCINE; IMMUNOSUPPRESSIVE AGENT; RIBAVIRIN; STEROID;

ADULT; AGED; AUTOIMMUNE DISEASE; CLINICAL FEATURE; CRYOGLOBULINEMIA; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; HEMATOLOGIC DISEASE; HEPATITIS C; HEPATITIS C VIRUS; HISTOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTOCLASTIC VASCULITIS; LYMPHOCYTE PROLIFERATION; MALE; NEOPLASM; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SYMPTOM;

EID: 0036143398     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.55.1.4     Document Type: Review

References (100)

1. Hyperproteinemia associated with multiple myeloma. With report of a case in which an extraordinary hyperproteinemia was associated with thrombosis of the retinal veins and symptoms suggesting Raynaud's disease
2. Cryoglobulinemia based on interaction between a gamma macroglobulin and 7S gamma globulin
3. Atypical glycosylation of an IgG monoclonal cryoimmunoglobulin
4. Abnormal glycosylation of serum IgG from patients with chronic inflammatory diseases
5. Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation
6. Cryoglobulinemia induced by monoclonal immunoglobulin G rheumatoid factor derived from autoimmune MRL/MpJ-Ipr/Ipr mice
7. Cryoglobulinemia. A clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity
8. Biologic and clinical significance of cryoglobulins
9. Mixed cryoglobulinemia: Clinical aspects and long-term follow-up of 40 patients
10. Association between hepatitis B virus and essential mixed cryoglobulinemia
11. Liver involvement in essential mixed cryoglobulinemia
12. Association between polyarteritis and Australia antigen
13. Essential mixed cryoglobulinemia without evidence for hepatitis B virus infection
14. Isolation of a cDNA clone derived from a blood-borne non-A non-B viral hepatitis genome
15. Hepatitis C virus in patients with cryoglobulinemia type II
16. Alpha-interferon in the treatment of mixed cryoglobulinemia patients
17. Hepatitis C virus and mixed cryoglobulinemia
18. Association between hepatitis C virus and mixed cryoglobulinaemia
19. A role for hepatitis C virus infection in type II cryoglubulinemia
20. Hepatitis C virus, B-cell disorders, and non-Hodgkin's lymphoma
21. Detection and distribution of hepatitis C-related proteins in lymph nodes of patients with type II cryoglobulinemia and neoplastic or non-neoplastic lymphoproliferation
22. Localization of hepatitis C virus in cutaneous vasculitic lesions in patients with type II cryoglobulinemia
23. Cryoglobulins are not essential
24. Cryoglobulinemia in chronic liver diseases: Role of hepatitis C virus and liver damage
25. Immunological disorders in C virus chronic active hepatitis: A prospective case-control study
26. Hepatitis C virus infection in type II mixed cryoglobulinemia
27. Mixed cryoglobulinemia: A cross-road between autoimmune and lymphoproliferative disorders
28. Relation between infection and autoimmunity in mixed cryoglobulinemia
29. Hepatitis C virus genotype analysis in patients with type II mixed cryoglobulinemia
30. HLA expression in type II mixed cryoglobulinemia and chronic hepatitis C virus
31. Haplotype HLA-B8-DR3 confers susceptibility to hepatitis C virus-related mixed cryoglobulinemia
32. Hepatitis C: A multifaceted disease. Review of extrahepatic manifestations
33. Hepatitis C virus and porphyria cutanea tarda: Evidence of a strong association
34. Hepatitis C virus-related autoimmunity in patients with porphyria cutanea tarda
35. Antibodies to hepatitis C virus in autoimmune liver disease: Evidence for geographical heterogeneity
36. Hepatitis C virus-associated glomerulonephritis
37. Hepatitis C virus as common cause of mixed cryoglobulinemia and chronic liver disease
38. Viruses and cancers: Possible role of hepatitis C virus
39. Thyroid cancer in patients with hepatitis C infection
40. Hepatitis C infection presenting with rheumatic manifestations: A mimic of rheumatoid arthritis
41. Cryoglobulinemic vasculitis
42. Infection of peripheral mononuclear blood cells by hepatitis C virus
43. Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia
44. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: Quasispecies nature of HCV genome distribution
45. Is there a link between viral hepatitis and lymphoproliferative disorders? From the autopsy room to the PCR thermal cycler
46. Hepatitis C virus infection in patients with non-Hodgkin's lymphoma
47. Hepatitis C virus infection in a subset of neoplastic lymphaproliferations not associated with cryoglobulinemia
48. B-cell malignancy and hepatitis C virus infection
49. Hepatitis C virus infection in patients with B-cell non-Hodgkin's lymphoma
50. The role of hepatitis C virus in the aetiology of non-Hodgkin's lymphoma - A regional association?
51. Hepatitis C virus infection in non-Hodgkin's lymphoma
52. Hepatitis C virus infection in non-Hodgkin's B-cell lymphoma complicating mixed cryoglobulinaemia
53. Low-grade malignant lymphoma, hepatitis C virus infection, and mixed cryoglobulinemia
54. Clonal B cell expansion in patients with essential mixed cryoglobulinemia
55. Essential mixed cryoglobulinemia, type II: A manifestation of low malignant lymphoma? Clinical-morphological study of 12 cases with special reference to immunohistochemical findings in liver frozen sections
56. Bone marrow findings further support the hypothesis that essential mixed cryoglobulinemia type II is characterized by a monoclonal B-cell proliferation
57. Hepatic lymphoid aggregates in chronic hepatitis C and mixed cryoglobulinemia
58. A revised European-American classification of lymphoid neoplasms: A proposal from the international lymphoma study group
59. Hepatitis C virus and non-Hodgkin's lymphoma
60. Clonality of B-cells in portal lymphoid infiltrates of HCV-infected livers
61. Type II mixed cryoglobulinemia is a non-malignant B-cell disorder. Clinical and molecular findings do not support bone marrow pathologic diagnosis of low grade B-cell lymphoma
62. Frequency of bcl-2 rearrangement in patients with mixed cryoglobulinemia and HCV-positive liver diseases
63. T(14;18) translocation in chronic hepatitis C virus infection
64. Bcl-2 rearrangement in patients with chronic hepatitis C associated with essential mixed cryoglobulinemia type II
65. Binding of hepatitis C virus to CD81
66. Bcl-2: A repressor of lymphocyte death
67. Monoclonal lymphocyte proliferation and bcl-2 rearrangement in essential mixed cryoglobulinaemia
68. Novel primitive lymphoid tumors induced in trangenic mice by cooperation between myc and bcl-2
69. HCV-associated liver cancer without cirrhosis
70. Pre-malignant and malignant lymphoproliferations in an HCV-infected type II mixed cryoglobulinemic patient are sequential phases of an antigen-driven pathological process
71. Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to a-interferon therapy
72. Helicobacter pylori gastritis and gastric MALT-lymphoma
73. Progression of gastritis to monoclonal B-cell lymphoma with resolution and recurrence following eradication of Helicobacter pylori
74. Principles and pharmacology of chemotherapy
75. Two-dimensional polyacrylamide gel electrophoresis analysis of cryoglobulins and identification of an IgM-associated peptide
76. Mixed cryoglobulinemia cross-reactive idiotypes: Implication for relationship of MC to rheumatic and lymphoproliferative diseases
77. Blood viscosity and filtration abnormalities in mixed cryoglobulinemia patients
78. Nomenclature of systemic vasculitides: Proposal of an international consensus conference
79. Cryoglobulinaemias: A multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease
80. Cryoglobulins and immune complexes in essential mixed cryoglobulinemia
81. Hypercomplementaemia as a marker of the evolution from benign to malignant B-cell proliferation in patients with type II mixed cryoglobulinaemia
82. Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to a-interferon therapy
83. Alpha-interferon in mixed cryoglobulinemia patients: A randomized crossover controlled trial
84. Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus
85. Long-term results of therapy with interferon-alpha for type II essential mixed cryoglobulinemia
86. Interferon toxicity in hepatitis C virus, associated type II cryoglobulinemia
87. Exacerbation of peripheral neuropathy during alpha-interferon therapy in a patient with mixed cryoglobulinemia and hepatitis B virus infection
88. Cryoglobulinemia and hepatitis C: Worsening of peripheral neuropathy after interferon alpha treatment
89. Successful treatment of HCV-associated cryoglobulinaemic glomerulonephritis with a combination of interferon-alpha and ribavirin
90. Treatment of refractory, symptomatic, hepatitis C virus related mixed cryoglobulinemia with ribavirin and interferon-alpha
91. Interferon alpha-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
92. Perspectives for a hepatitis C virus vaccine
93. Low-antigen-content diet in the treatment of mixed cryoglobulinemia patients
94. Treatment of renal involvement in essential mixed cryoglobulinemia with prolonged plasma exchange
95. Double filtration plasmapheresis in the treatment of cryoglobulinemic glomerulonephritis
96. Low-antigen-content diet in the treatment of patients with IgA nephropathy
97. Apheresis for renal disease
98. A quantitative study of the precipitin reactions between type III pneumococcus polysaccharide and purified homologous antibody